Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status

Minami, Seigo; Kijima, Takashi; Hamaguchi, Masanari; Nakatani, Takeshi; Koba, Taro; Takahashi, Ryo; Takeuchi, Yoshiko; Kida, Hiroshi; Nagatomo, Izumi; Yamamoto, Suguru; Tachibana, Isao; Komuta, Kiyoshi; Kawase, Ichiro

期刊名称Lung Cancer
作者Minami, Seigo; Kijima, Takashi; Hamaguchi, Masanari; Nakatani, Takeshi; Koba, Taro; Takahashi, Ryo; Takeuchi, Yoshiko; Kida, Hiroshi; Nagatomo, Izumi; Yamamoto, Suguru; Tachibana, Isao; Komuta, Kiyoshi; Kawase, Ichiro
卷第82卷
期第2期
印刷ISSN0169-5002
文件大小699.91KB
发表时间2013-11
DOI10.1016/j.lungcan.2013.07.022
页码271-275

发现好书期刊，享受阅读乐趣

Phase II study of pemetrexed plus intermittent erlotinib combination therapy for pretreated advanced non-squamous non-small cell lung cancer with documentation of epidermal growth factor receptor mutation status